Tectonic Therapeutic, Inc., or Tectonic, operates in the gene therapy industry, with its stock symbol being TECX. The company specializes in the development of potentially curative hematopoietic stem cell (HSC) gene therapies, targeting patients with rare diseases through a single-dose treatment regimen. Tectonic's business model revolves around developing and commercializing gene therapy products. The company has a robust product pipeline, with gene therapy programs such as AVR-RD-02 for Gaucher disease types 1 and 3, AVR-RD-03 for Pompe disease,...
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Inc / Ma | 112.75 Bn | 28.70 | 9.40 | - |
| 2 | ARGX | Argenx Se | 45.81 Bn | 33.41 | 1.22 | - |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.44 Bn | 152.67 | 13.47 | - |
| 4 | ZLAB | Zai Lab Ltd | 22.17 Bn | -125.22 | 91.43 | 0.20 Bn |
| 5 | RPRX | Royalty Pharma plc | 19.90 Bn | 27.02 | 8.37 | 8.95 Bn |
| 6 | ROIV | Roivant Sciences Ltd. | 19.49 Bn | -31.20 | 3,395.13 | - |
| 7 | RVMD | Revolution Medicines, Inc. | 19.31 Bn | -16.50 | 23,262.78 | - |
| 8 | MRNA | Moderna, Inc. | 19.29 Bn | -6.73 | 9.92 | 0.59 Bn |